The intestinal microbiome is increasingly thought to be a crucial factor in the development of obesity and diabetes (Palau-Rodriguez 2015
Interleukin-18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis
doi:10.2337/dc20-1815 6
Compounded medications are not FDA-approved finished drug products
This, in turn, boosts metabolic rate and activates a gene known as sirtuin-1 (SIRT1), also referred to as the "longevity gene." SIRT1 is involved in reducing the risk of various conditions such as diabetes, obesity, metabolic syndrome, atherosclerosis, cardiovascular disease, kidney disease, liver disease, neurodegeneration, and cancer.
Nick Barringer, Ph.D., R.D.N., is a nutritional physiologist, registered dietitian, and certified strength and conditioning coach